A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics

Here, we randomized 53 patients hospitalized with coronavirus disease 2019 (COVID-19) to hydroxychloroquine therapy (at a dose of 400 mg twice daily for seven days) in addition to standard care or standard care alone (ClinicalTrials.gov Identifier, NCT04316377). All severe acute respiratory syndrome...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyngbakken, Magnus Nakrem, Berdal, Jan-Erik, Eskesen, Arne, Kvale, Dag, Olsen, Inge Christoffer, Rueegg, Corina Silvia, Rangberg, Anbjørg, Jonassen, Christine Monceyron, Omland, Torbjørn, Røsjø, Helge, Dalgard, Olav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576792/
https://www.ncbi.nlm.nih.gov/pubmed/33082342
http://dx.doi.org/10.1038/s41467-020-19056-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576792/
https://www.ncbi.nlm.nih.gov/pubmed/33082342
http://dx.doi.org/10.1038/s41467-020-19056-6

Ejemplares similares